$250 | Single User
$500 | Site License
$750 | Enterprise License

U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Published by Global Data]

Published by Global Data: 10 May 2016 | 12034 | In Stock
Related Topics: Healthcare

Introduction

Summary

U.S. Renal Care Inc. (U.S. Renal Care) is a healthcare service provider that offers in-center and at-home hemodialysis and peritoneal dialysis services. The center supports dialysis centers with operations management, clinical leadership and trained clinical and support nursing staff. It operates through network of dialysis centers, home and specialty hospital dialysis programs and facilities. U.S. Renal Care provides home hemodialysis with the aid of a partner or additional services provided by its nursing staff. The center has its presence in Arkansas, Texas, Georgia, Ohio, Pennsylvania, Maryland, New Jersey, South Carolina, Virginia, and Oklahoma. U.S. Renal Care is headquartered in Plano, Texas, the US.

U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

    U.S. Renal Care Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

    U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

    U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

    U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9

    U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deal Details 10

    Venture Financing 10

    U.S. Renal Care Secures US million In Venture Financing 10

    Merger 11

    DSI Renal And U.S. Renal Care to Merge 11

    Acquisition 12

    Vantage Oncology Acquires Radiation Oncology Services of America From U.S. Renal Care 12

    U.S. Renal Care Acquires Dialysis Corporation of America 13

    U.S. Renal Care Inc. - Key Competitors 16

    Key Employees 17

    Locations And Subsidiaries 19

    Head Office 19

    Other Locations & Subsidiaries 19

    Appendix 21

    Methodology 21

    About GlobalData 21

    Contact Us 21

    Disclaimer 21

List Of Tables
in U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data]

List of Tables

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Key Facts 1

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

U.S. Renal Care Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

U.S. Renal Care Inc., Deals By Therapy Area, 2010 to YTD 2016 8

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9

U.S. Renal Care Secures US million In Venture Financing 10

DSI Renal And U.S. Renal Care to Merge 11

Vantage Oncology Acquires Radiation Oncology Services of America From U.S. Renal Care 12

U.S. Renal Care Acquires Dialysis Corporation of America 13

U.S. Renal Care Inc., Key Competitors 16

U.S. Renal Care Inc., Key Employees 17

U.S. Renal Care Inc., Other Locations 19

U.S. Renal Care Inc., Subsidiaries 20

List Of Figures, Charts and Diagrams
in U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data]

List of Figures

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

U.S. Renal Care Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

12034 | GDPH205911D

Number of Pages

21

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Renal Failure Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Market Access Impact: Renal Cell Carcinoma (US)
IntroductionMarket barriers boost net share for 6 major RCC treatments in US. Is your brand one of t...
01 May 2016 by FirstWord Pharma USD $4,995 More Info
Market Access Impact: Renal Cell Carcinoma (EU5)
IntroductionMarket barriers cause net share loss for 5 major RCC treatments in Europe. Is your brand...
01 May 2016 by FirstWord Pharma USD $4,995 More Info
Medical Affairs Reputations: Renal Cell Carcinoma (US)
IntroductionOpdivo’s medical affairs team working overtime to engage oncologists. Is it paying off?O...
01 Apr 2016 by FirstWord Pharma USD $5,995 More Info
Medical Affairs Reputations: Renal Cell Carcinoma (EU5)
Introduction4 medical affairs teams working hard to engage oncologists. Which one gets top marks? Eu...
01 Apr 2016 by FirstWord Pharma USD $5,995 More Info
U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryU.S. Renal Care, Inc. (U.S. Renal Care) is a healthcare service provider that offers in-cente...
17 Mar 2016 by Global Data USD $250 More Info
NPS+ Renal Cell Carcinoma (US)
IntroductionTwo brands lead the RCC treatment market. How does your brand stack up?US oncologists ma...
01 Feb 2016 by FirstWord Pharma USD $2,495 More Info
NPS+ Renal Cell Carcinoma (EU5)
IntroductionCompare 8 major RCC brands. Learn which one scores 6 times higher than any other?FirstVi...
01 Feb 2016 by FirstWord Pharma USD $2,495 More Info
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015SummaryGlobalD...
30 Oct 2015 by Global Data USD $2,500 More Info
Renal Cell Carcinoma: KOL Insight
IntroductionWill new checkpoint inhibitors revive immunotherapy in RCC?Renal Cell Carcinoma: KOL Ins...
01 Feb 2015 by FirstWord Pharma USD $7,900 More Info

This report is published by Global Data

Download Free Report Summary PDF

U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Bizwit Research and Consulting
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)
  • VPA Research